Tsafi Peery,Michael B. Mathews,Mainul Hogue,Hartmut Martin Hanauske-Abel
申请号：
US12840270
公开号：
US08603814B2
申请日:
2010.07.20
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided are methods for treating a NAD comprising administering to a patient suffering from a NAD a composition comprising an eIF5A inhibitor compound in an amount effective to prevent intracellular hypusination of eIF5A, whereby gene expression of NMD-susceptible mRNA is increased.
